Aims Thiopentone is administered as a racemate (rac-thiopentone) for induction of anaesthesia as well as for neurological and neurosurgical emergencies. The pharmacokinetics and pharmacodynamics of rac-thiopentone have been extensively studied but the component R-(+)-and S-(−)-enantiomers, until very recently, have been largely ignored. Methods The present study analyses the pharmacokinetics of R-(+)-and S-(−)-thiopentone in 12 patients given rac-thiopentone intravenously for induction of anaesthesia and five patients given a prolonged infusion of rac-thiopentone used for treatment of intracranial hypertension. Results The mean total body clearance (CL T ) and apparent volume of distribution at steady-state (V ss ) showed trends towards higher values for R-(+)-than for S-(−)-thiopentone in both patient groups; CL T and V ss of unbound fractions of R-(+)-and S-(−)-thiopentone, however, did not show these trends. The time courses of R-(+)-and S-(−)-thiopentone serum concentrations were so similar that EEG effect could not be attributed to one or other enantiomer. Serum protein binding for S-(−)-thiopentone was greater than for R-(+)-thiopentone ( P=0.02) and 24 h urinary excretion of R-(+)-thiopentone was greater than for S-(−)-thiopentone (P=0.03). In one patient, concomitant measurement of CSF and serum thiopentone concentrations found that serum: CSF equilibration of unbound fractions of both enantiomers was essentially complete. Conclusions The study was unable to determine any pharmacokinetic difference of clinical significance between the R-(+)-and S-(−)-thiopentone enantiomers and concludes that minor differences in CL T and V ss could be explained by enantioselective difference found in serum protein binding.
Introduction [7] having shown that S-(−)-thiopentone was more potent in terms of duration of sleep and apnoea in human subjects. Thiopentone is most commonly used for the induction of anaesthesia. It is also used to a lesser extent in the treatment There is no definitive published literature on the differential pharmacokinetic and pharmacodynamic effects of acute neurological and neurosurgical emergencies including closed head injury and refractory status epilepticus due of R-(+)-and S-(−)-thiopentone. Although pharmacodynamic studies are difficult to interpret when a drug is given to its ability to reduce intracranial pressure, cerebral blood flow and oxidative metabolism. as a racemate, recent studies, based upon separation of R-(+)-and S-(−)-thiopentone enantiomers using highThiopentone is a racemic drug (rac-thiopentone) used as an equimolar mixture of R-(+)-and S-(−) enantiomers.
performance liquid chromatography (h.p.l.c.) [8, 9] have provided evidence of differential pharmacokinetics after It is well established that the enantiomers of a racemic drug may possess different pharmacokinetic and pharmacodynamic administration of rac-thiopentone [10, 11] . The aim of the present study was to determine whether properties [1, 2] . The pharmacokinetics and pharmacodynamics of rac-thiopentone have been extensively investigated there is a pharmacokinetic difference between R-(+) and S-(−)-thiopentone which could result in a difference in the over many decades but most studies until very recently have ignored its enantiomeric duality, reporting only on the sum time course of effect following a single intravenous bolus of rac-thiopentone in human subjects. Blood and urine levels of enantiomer concentrations [3, 4] . This is despite Christensen & Lee [5] and Haley & Gidley [6] having of R-(+)-and S-(−)-thiopentone were measured by chiral h.p.l.c. [8] in concert with an evaluation of pharmacoldemonstrated that S-(−)-thiopentone was a more potent ogical effect by spectral frequency electroencephalographic (EEG) analysis. The study also investigated whether there S-(−)-thiopentone under conditions of prolonged intra-277 mg (range 125-500 mg), as decided by the treating anaesthetist on clinical grounds. Pancuronium or vecuronium venous infusion of rac-thiopentone when used for treatment of intracranial hypertension.
(8-14 mg) were also given by the anaesthetist at induction of anaesthesia in all 12 patients and a further 10-20 mg morphine sulphate was given in nine patients and 50-300 mg Methods fentanyl citrate in two patients at induction. Following induction of anaesthesia all 12 patients also received 1 g Two separate studies were performed to investigate whether there were differential pharmacokinetics of the thiopentone cephazolin. General anaesthesia was maintained during the operation using nitrous oxide: oxygen 251 and isoflurane enantiomers in humans. Study 1 was based upon intravenous bolus doses of rac-thiopentone used in induction and 0.5-1%. Arterial blood samples were collected from an indwelling maintenance of anaesthesia in surgical patients. Study 2 was based upon prolonged infusion of rac-thiopentone in patients cannula inserted prior to surgery for the purpose of intraoperative haemodynamic monitoring. Blood samples with neurological or neurosurgical emergencies including severe head injury. All patients or relatives gave informed
(1-2 ml) were collected at 1,3,5,7,10,15,30 and 60 min after rac-thiopentone administration into 5 ml tubes (SST Becton written consent. Approval for the studies was granted by the Medical Research Ethics Committee of Royal North Dickinson and Co.). Further samples were taken every 1-2 h following administration of the thiopentone until Shore Hospital.
removal of the arterial cannula after surgery, with a total post-dose sampling time of 180-480 min (average: 280 min).
Study 1
The maximal sampling time was limited by the Ethics Committee approval which required cessation of blood Twelve patients (seven male, five female) undergoing back surgery (six lumbar and six cervical laminectomies and/or sampling after removal of the arterial cannula. Twenty-four hour urine samples were also collected in eight patients. fusions) by the same surgical and anaesthetic team at Royal North Shore Hospital (RNSH) were enrolled in this study. The mean age of subjects was 62 years (age range Electroencephalographic analysis years). All patients had no prior history of cardiac failure, renal or hepatic dysfunction. Five patients were otherwise Eight channel bipolar EEG (electroencephalographic) recordings (Fp1-F3, Fp2-F4, F3-C3, F4-C4, C3-P3, C4 -P4, healthy and on no regular medications. Intercurrent problems in the remaining seven subjects included well controlled F4-F3, P4-P3) were performed successfully in eight patients. Leads were placed in accordance with the international hypertension in five, non-insulin dependent diabetes mellitus in three, previous peptic ulcer disease in one and rheumatoid 10/20 system [12] . After gentle scrubbing of the scalp with Omniprep (D.O. Weaver and Co) abrasive solution and arthritis in one. Individual patient details are given in Table 1 .
Approximately 30 min prior to induction of anaesthesia, attachment of silver/silver chloride disc electrodes to the relevant scalp site using B5 collodion (Specialised Laboratory morphine sulphate (10 mg) and atropine sulphate (0.6 mg) were given as premedication in six patients, pethidine Equipment Ltd), electrodes were connected to a Vickers Medical Medelec DG 32 Compact EEG recorder. Baseline hydrochloride (100 mg) in one patient and temazepam (10 to 20 mg) and metoclopramide (10 mg) in the remaining EEG recording was performed in six of the eight patients for a minimum of 5 min prior to induction of anaesthesia five patients. Rac-thiopentone sodium (Abbott Australasia, 50 mg ml −1 ) was given as an intravenous bolus injection and in all eight patients for at least 60 min after intravenous injection of rac-thiopentone. Baseline EEG monitoring was over 10 s. The mean dose of rac-thiopentone used was Power spectrum analysis, a measurement of power or Within 30-60 min of collection all blood samples were centrifuged at 3000 rev min −1 for 10 min and the serum vertical peak of a sampled EEG region against frequency values for the same region of EEG, was performed on the was stored at −20°C until analysis. Measurement of thiopentone enantiomer concentrations in serum, urine, recordings of all eight patients. The spectral edge was defined as the upper boundary of that frequency containing buffer and CSF was performed within 3 weeks of collection by the chiral stationary phase h.p.l.c. method described by 95% of the total power in the channel's power spectrum. The median frequency was the frequency at which half the Huang et al. [8] . The limit of quantitation for R-(+)-and S-(−)-thiopentone in serum, buffer and urine were total power was below and half the total power above that frequency. Spectral EEG data were analysed from the time 5 ng ml −1 and 6 ng ml −1 respectively (signal to noise ratio >451). At concentrations ranging from 1-100 mg ml −1 in of onset of induction of anaesthesia with rac-thiopentone to 10 min following induction. Results of mean values of serum, buffer and urine, the recovery of R-(+)-and S-(−)-thiopentone enantiomers was greater than 70% and spectral edge and median frequencies were documented for all eight patients before, then every 30 s following the there was less than 5% loss of recovery of R-(+)-or S-(−)-thiopentone when serum and buffer samples were intravenous injection of thiopentone for 5 min and every 60 s for a further 5 min for each of the eight bipolar channels stored at −20°C for 3 months. The intra-day and interday variabilities for the measurement of R-(+)-and used. It is acknowledged that the EEG could have been influenced by the other medications administered but it is S-(−)-thiopentone in serum, buffer and urine were less than 8%. The calibration curves were linear with r 2 believed that thiopentone produced the dominant drug effect during this time frame. coefficients greater than 0.99. Urine was kept in sterile 4 l glass containers at room temperature until completion of each 24 h collection. A Study 2 preliminary study, performed and repeated under similar conditions with known concentrations of R-(+)-and Five patients receiving prolonged intravenous infusions of rac-thiopentone sodium (Abbott Australasia) and undergoing S-(−)-thiopentone enantiomers and known urine volumes, excluded any significant loss of recovery of thiopentone in arterial blood sampling during and for a maximum of 5 days post-infusion were studied. There were four male patients urine by this method. The total volume of urine was quantitated and 10 ml of urine was stored at −20°C and one female patient, mean age 32 years (range 20-47 years). The mean total dose of rac-thiopentone was 37.6 g until analysis.
Serum protein binding analysis was performed using (range 26.1 to 54.5 g) given over a mean total duration of 62.6 h (range 31 to 92 h). Details of individual patients are pooled serial serum samples of six patients from study 1 and four patients from study 2. Equilibrium dialysis was given in Table 2 .
Rac-thiopentone infusion was commenced to reduce performed in glass cells containing 2 ml serum adjusted to pH 7.4 by the addition of 10-20 ml 0.5 M H 3 PO 4 and intracranial pressure and/or cerebral oxidative metabolism in all five patients: three had suffered severe head injury separated by a cellulose membrane (Selbys Scientific Ltd) from 2 ml pH 7.4 0.067 m phosphate buffer solution. The following motor vehicle accidents, one a subarachnoid haemorrhage due to aneurysmal rupture and one cerebral glass cells were equilibrated at 35°C for 8 h. At the completion of equilibration, pH measurement confirmed venous sinus thrombosis (patient 17). Two of the patients with severe head injury died during hospitalisation, patient 15 that no change occurred during dialysis and protein dipstick testing (Bayer Diagnostic Multistix 8 SG) of phosphate within 12 h of cessation of rac-thiopentone infusion from the effects of a closed head injury and patient 14 5 days buffer confirmed there was no leakage of protein across the cellulose membrane. The mean post-dialysis serum confollowing completion of rac-thiopentone infusion as a result of sepsis and post-traumatic pancreatitis.
centrations of R-(+)-and S-(−)-thiopentone were 0.57 mg ml −1 (range 0.17-1.5 mg ml −1 ) and 0.58 mg ml
CSF was collected at regular intervals during and following infusion of rac-thiopentone in patient 17.
(range 0.32-1.4 mg ml −1 ), respectively for patients in 
.4-39.4 mg ml −1 ) and 25.5 mg ml −1 (range 13.3-43.6 mg ml −1 ), respectively for patients in study 2.
Pilot studies confirmed that there was no significant or differential binding of thiopentone enantiomers to the cellulose membrane used and that equilibration of thiopentone enantiomers across the membrane was achieved within 8 h. Pooled cerebrospinal fluid (CSF) from patient 17 of study 2, stored after collection at −20°C, was also used to determine the degree of protein binding of R-(+)-and S-(−)-thiopentone enantiomers using the same technique. squared of the concentration as a weighting factor was applied to analyse serum concentration-time data for study 1 [13] . This approach gave the simplest model that fit the data excretion and serum protein binding in study 1 and statistical analysis of results are given in Table 3 . R-(+)-to without skew to the residuals. The initial dilution volume (V c ), total apparent volume of distribution at steady-state S-(−)-thiopentone ratios of the above parameters for individual patients in study 1 are given in Table 1 . (V ss ) of total and unbound fractions, the mean total body clearance (CL T ) of total and unbound fractions and mean
For the 12 patients in study 1, CL T and V SS showed trends to higher values for R-(+)-than residence time (MRT) of the separate thiopentone enantiomers were calculated using standard equations [13] . For
S-(−)-thiopentone and the 24 h urinary excretion of R-(+)-thiopentone exceeded that of S-(−)-thiopentone. study 2, CL T was calculated from the ratio of the mean infusion rate for the last 12 h to the mean serum thiopentone A concentration-dependent difference in the ratio of R-(+)-:S-(−)-thiopentone enantiomer serum protein bindenantiomer concentration measured during this period. The doses of R-(+)-and S-(−)-thiopentone enantiomers for
ing was not observed when studies 1 and 2 were compared (P=0.2), although the patient numbers were small. Analysis studies 1 and 2 were deemed to be half the dose of racthiopentone.
of data for 10 patients (6 patients from study 1 and 4 patients from study 2) showed that the fractional serum protein Due to the relatively brief duration of sampling time, the emphasis of data analysis in study 1 was a comparison of the binding of S-(−)-thiopentone was higher than that of R-(+)-thiopentone ( P=0.02). When normalised by the two enantiomers. This method of analysis was held to be valid given that the enantiomer concentrations were appropriate free fractions in the six patients from study 1 the trends in CL T and V SS were no longer apparent determined in the same serum samples and thus under concurrent and identical circumstances. The limitations of suggesting that enantioselective protein binding was responsible for the trends observed in pharmacokinetic parameters. the approach, however, are acknowledged with a drug having a long apparent terminal half-life as does thioIn only one patient (7 of study 1), was the protein binding of R-(+)-thiopentone greater than S-(−)-pentone [14] .
Values for CL T , V SS , MRT, 24 h urinary excretion, and thiopentone. However the absolute difference was small. It is of interest that patient 7 was the only patient fractional serum protein binding of R-(+)-and S-(−) thiopentone were not found to deviate significantly from from studies 1 and 2 to demonstrate considerably higher CL T and V SS of S-(−)-compared to R-(+)-thiopentone. normality (Wilks-Shapiro test) and were compared using Student's t-test for paired data as well as the Wilcoxon Median frequency spectral EEG analysis of the eight patients in study 1 who had EEG monitoring during surgery Signed Rank test.
Mean values of R-(+)-and S-(−)-thiopentone serum demonstrated initial slowing to delta frequency range (<4 Hz) within 30 s of commencement of a single concentrations for the eight patients who underwent EEG analysis at 1,3,5,7 and 10 min following intravenous bolus intravenous bolus of rac-thiopentone and reversion to beta frequency (> 12 Hz) after 180 s. At approximately 8 min injection were also plotted against mean spectral edge and median frequency EEG results for all channels used in post-administration of rac-thiopentone there was a transient increase in median frequency most probably due to each patient.
concomitant stimulation from intubation which was performed at approximately this time in the majority of patients.
Results
Initial EEG changes were simultaneous, symmetric and generalised in that similar intraindividual spectral edge and The mean time course for R-(+)-and S-(−)-thiopentone enantiomers of all 12 patients in study 1 is shown in median frequency findings were evident at all eight channels of EEG recording. The time course of the median and Figure 1 . The pharmacokinetic parameters for R-(+)-and S-(−)-thiopentone including CL T , V ss , 24 h urinary spectral edge frequency EEG data for F4-F3 (average results Table 3 Comparative pharmacokinetic data and statistical analysis of the difference between R-(+)-and S-(−)-thiopentone enantiomers when administered as rac-thiopentone in study 1. properties of the enantiomers of thiopentone when the racemate or individual enantiomers are given as a single bolus injection or prolonged infusion in human subjects had not been described until recently.
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The pharmacokinetic data obtained from our two patient groups in study 1 and 2 indicate there are only minor differences between the two thiopentone enantiomers when the drug is given in its pharmacopoeal form as the racemate. The 24 h urinary excretion of unmetabolised thiopentone was small (<1%) following a single intravenous bolus recently described by Mather et al. [10] in sheep and by Nguyen et al. [11] in human subjects.
injection and is consistent with the findings of Carroll et al. [15] who reported a 0.3-0.4% recovery of unchanged forms differences in the absolute levels of R-(+)-and S-(−)-thiopentone enantiomers following rac-thiopentone of R-(+)-and S-(−)-thiopentone. The enantiomeric difference in renal excretion of R-(+)-and S-(−)-induction in our patient population including during the first few minutes post-induction and hence this study was thiopentone found in our study, although minor, was statistically significant and is also most probably due to the unable to distinguish whether one or other enantiomer contributed more to the pharmacological EEG effect. higher free fraction of R-(+)-than S-(−)-thiopentone.
Analysis of R-(+)-and S-(−)-thiopentone CSF concenIn conclusion, our study indicates that there are minor differences in the time course of the R-(+)-and S-(−)-trations in patient 17 indicate that under infusion conditions the equilibration of R-(+)-and S-(−)-enantiomers across enantiomers when rac-thiopentone is administered as an intravenous injection or under conditions of prolonged the blood-brain-barrier into CSF is essentially complete and is consistent with passive diffusion of unbound fractions.
intravenous infusion. Moreover, a lack of intrinsic enantioselective pharmacokinetic differences between R-(+)-and Overall, no clinically significant difference in CSF distribution was noted between R-(+)-and S-(−)-thiopentone.
S-(−)-thiopentone is seen when CL T and V SS are determined for unbound fractions of both enantiomers. Studies In general, the pharmacokinetics of rac-thiopentone may be adequately described by first-order kinetic principles such as this, however, are unable to address the issue of whether there is a pharmacodynamic advantage of one or under conditions of a intravenous injection or brief infusion [4, 14, 16] . Studies have reported a decrease in steady state other enantiomer and further research into this area may enhance our understanding of the actions and clinical clearance with increasing plasma concentrations such that nonlinear or Michaelis-Menten kinetics apply after prolonged application of rac-thiopentone and its enantiomers. or high-dose intravenous infusions [17] [18] [19] . Similar obser-
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The present study also determined the time course of EEG effects of rac-thiopentone in relation to the serum References concentrations of its enantiomers. Avram et al. [20] found a
